Discovery Boost Grants (DBG) support investigators pursuing innovative cancer research, funding methodology development, feasibility studies, and pilot tests to open new areas of investigation.
Funder: American Cancer Society
Due Dates: December 1, 2026 (Winter cycle) | June 1, 2027 (Summer cycle)
Funding Amounts: Up to $135,000 annually for two years, plus 10% indirect costs ($297,000 maximum total)
Summary: Supports high-risk, high-reward exploratory cancer research through methodology development, feasibility studies, and pilot testing.
Key Information: Winter 2026 applications are restricted to the ACS–Fanconi Cancer Foundation DBG RFA and must match its scientific scope.
The American Cancer Society’s Discovery Boost Grants support exploratory research across the cancer research continuum. Administered through the Extramural Discovery Science Department, the program funds development of research methodologies, feasibility studies, and pilot tests of high-risk, high-reward ideas. Projects must be highly innovative rather than continuations of investigators’ current work.
The goal is to generate findings and preliminary data that can open new areas of investigation and help investigators secure further research funding. Preliminary data are permitted but not required at application, although strong supporting data or evidence are viewed favorably during review. The standard mechanism is paused for Winter 2026 while ACS refines the program, with applications restricted to the specified RFA.